FilingReader Intelligence

GlaxoSmithKline Pharmaceuticals to consider first quarter results

July 4, 2025 at 07:10 PM UTCBy FilingReader AI

GlaxoSmithKline Pharmaceuticals Limited announced that a meeting of its Board of Directors will take place on Friday, August 1, 2025, to review and approve the unaudited financial results for the first quarter ended June 30, 2025. The announcement, made in accordance with Listing Obligations and Disclosure Requirements Regulations, 2015, was submitted to the BSE. The company is headquartered in Mumbai.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when GlaxoSmithkline Pharmaceuticals publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →